SCHEMBL9764229

SCHEMBL9764229

CN1CCc2cc(Cl)c(N)cc2[C@@H](c2ccccc2)C1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 14/20 0.73
DRD2 P14416 4/20 0.73
HSD17B10 Q99714 4/20 0.73
CYP2D6 P10635 4/20 0.73
DRD5 P21918 3/20 0.73
CYP1A2 P05177 3/20 0.73
TSHR P16473 3/20 0.73
THPO P40225 2/20 0.73
CYP3A4 P08684 2/20 0.73
NFKB1 P19838 1/20 0.73
MEN1 O00255 1/20 0.73
ALOX15 P16050 1/20 0.73
KMT2A Q03164 1/20 0.73
SIGMAR1 Q99720 1/20 0.73
LMNA P02545 1/20 0.72
ADRB2 P07550 1/20 0.72
GPR183 P32249 1/20 0.72
APLNR P35414 1/20 0.72
GLP1R P43220 1/20 0.72
CX3CR1 P49238 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9764363 1.00 DRD1 (0.73) DRD1DRD2HSD17B10CYP2D6DRD5
SCHEMBL10744149 0.89 DRD1 (0.81) DRD1DRD2HSD17B10CYP2D6DRD5
SCHEMBL14199982 0.86 DRD1 (0.75) DRD1DRD2HSD17B10CYP2D6DRD5
SCHEMBL9764281 0.86 DRD1 (0.75) DRD1DRD2HSD17B10CYP2D6DRD5
Sch-23390 SCHEMBL29797998 0.85 DRD1 (1.00) DRD1DRD2HSD17B10CYP2D6DRD5
Sch-23390 SCHEMBL30628012 0.85 DRD1 (1.00) DRD1DRD2HSD17B10CYP2D6DRD5
Sch-23390 SCHEMBL11107859 0.85 DRD1 (1.00) DRD1DRD2HSD17B10CYP2D6DRD5
Sch-23390 SCHEMBL2916216 0.85 DRD1 (1.00) DRD1DRD2HSD17B10CYP2D6DRD5
Sch-23390 SCHEMBL16187032 0.85 DRD1 (1.00) DRD1DRD2HSD17B10CYP2D6DRD5
Sch-23390 SCHEMBL29424268 0.85 DRD1 (1.00) DRD1DRD2HSD17B10CYP2D6DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4996202-A 1,2,4,5 tetrahydro benzazepine-3 compounds and antipsychotic use thereof SCHERING CORPORATION (US) 1991-02-26 US claimed
US-7211574-B2 Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders SCHERING CORPORATION (US) 2007-05-01 US disclosed
US-7211574-B2 Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders SCHERING CORPORATION (US) 2007-05-01 US disclosed
US-4996202-A 1,2,4,5 tetrahydro benzazepine-3 compounds and antipsychotic use thereof SCHERING CORPORATION (US) 1991-02-26 US disclosed
EP-0153400-A1 BENZAZEPINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THE PREPARATION OF SUCH COMPOUNDS AND COMPOSITIONS SCHERING CORPORATION (US) 1985-09-04 EP disclosed
EP-0135767-A1 Benzazepine derivatives, pharmaceutical compositions containing them and processes for the preparation of such compounds and compositions SCHERING CORPORATION (US) 1985-04-03 EP disclosed
WO-1985000808-A1 BENZAZEPINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THE PREPARATION OF SUCH COMPOUNDS AND COMPOSITIONS SCHERING CORP. (US) 1985-02-28 WO disclosed